Altimmune, Inc. (ALT) Revenue 2016–2025
Altimmune, Inc. (ALT) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$41,000FY2025 · since FY2016: $3.2M → $41,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $41,000 | +105.0% |
| FY2024 | $20,000 | -95.3% |
| FY2023 | $426,000 | +726.5% |
| FY2022 | -$68,000 | -101.5% |
| FY2021 | $4.4M | -46.1% |
| FY2020 | $8.2M | +41.1% |
| FY2019 | $5.8M | -43.8% |
| FY2018 | $10.3M | -3.8% |
| FY2017 | $10.7M | +231.8% |
| FY2016 | $3.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice